Core Insights - Siemens Healthineers showcased numerous innovative products at the sixth China International Import Expo, emphasizing their commitment to healthcare innovation [1][2] - The company has deep roots in the Chinese market, having established a significant presence over the past 30 years, which has contributed to the development of the local healthcare industry [3] Product Innovation - Siemens Healthineers introduced the world's first photon-counting CT, which has received approvals from FDA, CE, and NMPA, marking a revolutionary advancement in CT technology [2] - The photon-counting CT was approved in China in October, significantly reducing the time for market entry through an expedited review process [2] Market Strategy - The company has invested 1 billion RMB to establish a high-end medical equipment R&D and production base in the Greater Bay Area, enhancing its production capacity and R&D resources [4] - Siemens Healthineers operates six production bases in China, with plans for production upgrades at its Wuxi facility to enhance CT component manufacturing [6] Global Contribution - Siemens Healthineers aims to leverage Chinese innovations for global markets, contributing to the global healthcare landscape [5] - The company is building a multi-dimensional innovation ecosystem by integrating local innovations with its global expertise [6]
进博故事丨西门子医疗王皓：国智创新 扎根中国服务全球
Xin Hua Wang·2025-08-12 05:48